How Life Sciences L&D Teams Are Upskilling Workforces Before AI Makes Their Current Skills Obsolete

[Infopro Learning]

Upskilling the life sciences workforce is always a moving target. In January 2026, the FDA and the EMA published ten principles around the use of AI in drug development, and both consider them the basis for further guidelines yet to be written. It sounds like your regulatory expert’s role is just the same. But the tools and the regulator are not. This guide explains why this skills gap differs from previous ones, where it manifests and what your L&D experts can do about it.

What’s Inside the Guide:

• Chapter 1: Why This Skills Gap Doesn’t Behave Like the Last One: Learn why a moving compliance target breaks standard training plans.
• Chapter 2: What’s Actually Changing, Function by Function: See how AI reaches research, clinical, manufacturing, safety, and regulatory affairs.
• Chapter 3: What This Means for How L&D Should Respond: Take three conclusions from primary sources into your investment case.
• Chapter 4: A Working Framework for Closing the Gap: Build workforce upskilling around seven action items, from risk mapping to standing infrastructure.
• Chapter 5: Implementation Checklist: Assign owners and review cadences for every action, from quarterly to per regulatory publication.

The post How Life Sciences L&D Teams Are Upskilling Workforces Before AI Makes Their Current Skills Obsolete first appeared on Infopro Learning.